The principles of care for patients with intermittent claudication

Česká verzia

Authors: K. Roztočil
Authors place of work: Klinika transplantační a cévní chirurgie IKEM Praha, přednosta prof. MUDr. Miloš Adamec, CSc.
Published in the journal: Vnitř Lék 2010; 56(7): 724-726
Category: 80th Birthday - Jaroslava Blahoše, MD, DrSc.

Summary

Patients with claudication have a high cardiovascular risk and, foremost, require an introduction of the appropriate procedures to stop the progression of the disease and to prevent cardiovascular events as if these were patients with a coronary or cerebrovascular disease. To manage the claudication-associated complaints, surgery and endovascular revascularization procedures, exercise therapy and vasoactive agents with proven clinical efficacy are used.

Key words:
atherosclerosis – intermittent claudication – endovascular revascularization – vasoactive treatment

Zdroje

1. Goodney PP, Beck AW, Nagle J et al. National trends in lower extremity bypass surgery, endovascular interventions, and major amputations. J Vasc Surg 2009; 50: 54–60.

2. Norgren L, Hiatt WR, Dormandy JA et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg 2007; 33 (Suppl 1): S1–S75.

3. Sobel M, Verhaeghe R. Antithrombotic therapy for peripheral artery occlusive disease. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133 (Suppl 6): 815S–843S.

4. Consensus of Central European Vascular Forum on Intermittent Claudication. Milano: Adis International 2005: 1–27.

5. Gardner AW, Montgomery PS, Parker DE. Physical activity is a predictor of all‑cause mortality in patients with intermittent claudication. J Vasc Surg 2008; 47: 117–122.

6. Katzmarzyk PT, Church TS, Craig CL et al. Sitting time and mortality from all causes, cardiovascular disease, and cancer. Med Sci Sports Exerc 2009; 41: 998–1005.

7. Diehm C, Darius H. Atherothrombose – Risikopradiktion und stratifizierung, Biomarker, nichtinvasive Diagnostik, multiple Eriegnisse und Therapie. Gefaessmedizin 2007; 3: 4–28.

8. McDermott MM, Mehta S, Ahn H et al. Atherosclerotic risk factors are less intensively treated in patients with peripheral arterial disease than in patients with coronary artery disease. J Gen Intern Med 1997; 12: 209–215.

9. D’Souza J, Patel NN, Rocker M et al. Management of cardiovascular risk factors by primary care physicians in patients with peripheral arterial disease. Surgeon 2008; 6: 144–147.

10. Selvin E, Hirsch AT. Contemporary risk factor control and walking dysfunction in individuals with peripheral arterial disease: NHANES 199–2004. Atherosclerosis 2008; 201: 425–433.

11. Welten GM, Schouten O, Hoeks SE et al. Long‑term prognosis of patients with peripheral arterial disease: a comparison in patients with coronary artery disease. J Am Coll Cardiol 2008; 51: 1588–1596.